UN&UP
UN&UP is a technology development company founded by life-science entrepreneurs developing therapies to equalize care disparities for underserved populations.
Foundations
The company was founded in 2018 by life-science entrepreneurs with deep experience in neurology, nanoparticles, cardiology, robotics, magnetics, NIH-funded multidisciplinary efforts, regulatory affairs, clinical study design, animal models, and device design. UN&UP has offices in the Cambridge Innovation Center in St. Louis, Missouri and maintains an advanced robotics lab (~2,500 ft2) within the historic St. Louis Midtown. Wet lab space is contracted through the St. Louis BioGenerator which possesses state-of-the-art facilities and controls to handle chemicals and biological materials.
Our Mission
The company is a technology development business founded by experienced life-sciences entrepreneurs developing breakthrough therapies to equalize care disparities. We partner with the NIH SBIR program to de-risk novel transformative technologies which promise to redefine current standards of care. UNandUP has earned multiple NIH awards to develop several advanced magnetic control technologies including nanomagnetic substrates for ischemic stroke, neuroprotection, chemotherapy, immunotherapy and tumor embolization, and next-generation interventional robotic systems to improve patient outcomes in procedures in the brain, heart and lungs. When derisked, UNandUP creates new companies focused on rapid commercialization around these novel technologies.